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1. Introduction
  Telomerase is a reverse transcriptase that uses RNA as a 
template to synthesize DNA repeats in order to maintain 
telomere length[1-3]. Telomerase reverse transcriptase 
(TERT) is the catalytic subunit of telomerase, and the TERT 
expression level has a strong correlation with the activity 
of telomerase[4-7]. Introduction of the TERT gene into 
transfected cells leads to stable expression of telomerase, 
maintenance of chromosomal integrity, and long-term 
sustainability of cell growth[8-10]. We constructed the 
retroviral vector pLEGFP-N1-TERT and transfected 293FT 
packaging cells with the vector by calcium phosphate 
coprecipitation to obtain high-titer virus. Neonatal 
mouse hypodermal cells were infected with the virus and 
screened for positive clones showing stable expression of 
TERT and green fluorescence protein under a fluorescent 
microscope. This primary study provides the foundation for 
a potential new method of labeling seed cells for skin tissue 
engineering. 
  
2. Materials and methods
2.1. Reagents
  All animal experiments were carried out according to 
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the guidelines of the Institutional Animal Care and Use 
Committee. Neonatal C57BL/6 mice were provided by 
the Experimental Animal Center of Southern Medical 
University. Plasmid pLEGFP-N1, packaging plasmid PIK, 
competent cell line STBL3, and packaging cell line 293FT 
were purchased from Wuhan Bozhou Biotechnology Co., 
Ltd., China. Type I collagenase and dispase were from 
Gibco, USA. DNA fragment purification kit, agarose gel 
DNA purification kit, MiniBEST Plasmid Purification Kit, 
NucleoBond Plasmid Maxi Kit, Hind 栿, Sal 栺, BamH 栺, T4 
DNA ligase, and DNA ligation kit were from TaKaRa, Japan. 
Lipofectamine 2000 was from Invitrogen, USA. Anti-TERT 
antibody was from Epitomics, USA. Primers were synthesized 
by Invitrogen Co., Shanghai, China.
2.2. Primer design for gene cloning
  Primers were designed on the basis of pLEGFP-N1 
expression vector map (Figure 1). The sequence of the TERT 
gene was obtained from NCBI (NM: 009354), and primers 
were designed as follows: 
TERT-F: 5' CCCAAGCTTATGACCCGCGCTCCTCGTTG 3'; 
TERT-R: 5' ACGCGTCGACCGGTCCAAAATGGTCTGAAAGTC
TGT 3'. 
Figure 1. Map of expression vector pLEGFP-N1.
2.3. Construction of retroviral vector pLEGFP-N1-TERT
  Total RNA was isolated from livers of neonatal mice, cDNA 
was synthesized, and the PCR product was detected by 
agarose gel electrophoresis. Subsequently, 3 369 bp DNA 
fragments were recovered from the gel. These fragments and 
the pLEGFP-N1 vector were digested with Hind 栿 and Sal 
栺 and then ligated with T4 DNA ligase to generate pLEGFP-
N1-TERT. The ligation product was transformed into STBL3 
competent cells. Colonies were identified by colony PCR 
and restriction enzyme digestion and finally confirmed by 
DNA sequencing of double strands (Invitrogen Co., Shanghai, 
China). Positive colonies were cultured in Lysogeny broth, 
and plasmids were purified and verified by BamH栺
digestion.
2.4. Retrovirus packaging
  
  Plasmids pLEGFP-N1 (used as a control) and pLEGFP-N1-
TERT were transformed into separate STBL3 cell cultures. 
Amplified recombinant plasmids were extracted by CsCl 
density gradient centrifugation and co-precipitated with 
calcium phosphate for transfection into 293FT packaging 
cells.
2.5. Isolation and culture of hypodermal cells
  Skin from the backs of newborn C57 mice was dissociated, 
cut into 0.5 cm 暳0.5 cm tissue masses, and digested with 
0.1% neutral protease overnight at 4 曟. Derma and epiderma 
were separated with dissecting forceps. Derma were cut into 
pieces, digested with 0.2% collagenase at 37 曟 for 30 min, 
and then filtrated through a 200-mesh sieve. Single cells 
were collected and cultured in Dulbecco’s modified Eagle’s 
medium, a high glucose complete medium, containing 10% 
fetal bovine serum. The cells after 3 passages were used for 
subsequent experiments.
2.6. Titer determination and retroviral infection
  Supernatants containing pLEGFP-N1- or pLEGFP-N1-
TERT-carrying retroviruses were filtered by using 0.45-毺
m filters. Neonatal mouse hypodermal cells were infected 
with retrovirus plus polybrene (2 毺g/mL). The transfected 
cells were selected by resistance to the antibiotic G418, and 
stable cell lines were subcultured after a 7-day selection. 
Retrovirus titer was calculated by using the following 
formula: titer (PFU/mL) = number of GFP positive cells × 
dilution factor/0.01 mL.
2.7. Expression of TERT in neonatal mouse hypodermal cells
  After infection, stable cell lines were selected for 
resistance to G418. Fluorescence in cells was observed 
under a fluorescence microscope. Western blot and 
immunohistochemical assay were performed to test the 
expression levels of TERT protein. The primary antibody was 
diluted 1:100.
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3. Results
3.1. Identification of construct
  
  Analysis of PCR products by agarose gel electrophoresis 
showed a 3 369 bp DNA fragment, which was consistent with 
the size of the target gene (Figure 2). 
  Extracted plasmid digested with BamH栺produced a 
fragment of approximately 1 800 bp (Figure 3), indicating that 
TERT has been inserted into the pLEGFP-N1 vector. DNA 
sequencing verified that the sequence was correct.
1      M
4 500 bp
3 000 bpTERT 3 369 bp
Figure 2. Electrophoresis of PCR-amplified TERT fragment.
Lane 1, TERT fragment (3 369 bp), indicating successful amplification 
of the target sequence, and lane M, Marker (bands from top to bottom 
are 4 500 bp, 3 000 bp, 2 250 bp, 1 500 bp, and 1 000 bp).
1        M
4 500 bp
2 250 bp
1 500 bp
1 800 bp
Figure 3. Identification of recombinant plasmid pLEGFP-N1-TERT 
by BamH栺digestion.  
Lane 1, the shorter fragment of approximately 1 800 bp is of the 
expected size, and lane M, Marker (bands from top to bottom are 4 500 
bp, 3 000 bp, 2 250 bp, 1500 bp, and 1 000 bp).
3.2. Exogenous expression of TERT in mouse hypodermal 
cells infected with retrovirus
  According to our calculations, the titer of retrovirus was 1.0 
暳10
9 PFU/mL. Cells stably expressing GFP attached within 
24 h after split. The cells first appeared round and non-
uniform in size, with high nuclear/cytoplasmic ratios. The 
cells then gradually extended to be short spindle-shaped, 
polygonal, or spindle-shaped. Green fluorescence was 
observed under a fluorescent microscope (Figure 4). Seven 
days after split, the primary cultured cells reached 70%-80% 
confluency.
  Expression of TERT was detected by western blot and 
immunohistochemical analysis, both of which showed 
significantly increased expression of TERT after infection 
(Figures 5 and 6, respectively).
Figure 4. Expression of EGFP in hypodermal cells 4 days after 
infection with retrovirus (100暳). 
TERT
毬-actin
Figure 5. Comparison of TERT expression levels between pLEGFP-
N1- and pLEGFP-N1-TERT-infected cells by western blot. 
pLEGFP-N1 (left) and pLEGFP-N1-TERT (right).
Figure 6. Comparison of TERT expression levels between pLEGFP-
N1- and pLEGFP-N1-TERT-infected cells by immunohistochemical 
assay. 
pLEGFP-N1 (left) and pLEGFP-N1-TERT (right) (200暳).
4. Discussion
   The seed cell is the most basic and most important part 
of tissue engineering. Adult cells usually reach senescence 
and lose normal cell functions after several passages under 
culture conditions. This restricts the application of adult 
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cells as the source of seed cells[11-15]. Homayoun et al 
introduced TERT into human fibroblasts, which activated 
the expression of telomerase and extended the telomere 
length and cell lifespan, but did not affect the growth, 
differentiation, and other biological characteristics of 
cells[16-20]. These findings suggested that immortalized cells 
can be used as seed cells for tissue engineering.
  In this study, we successfully constructed the retroviral 
vector pLEGFP-N1-TERT. After transfection into 293FT 
cells, virus with a titer of up to 1.0暳10
9 PFU/mL was 
produced. After infection of mouse hypodermal cells, 
expression of TERT increased significantly, and expression 
of green fluorescent protein facilitated cell labeling. This will 
not only meet the requirements of long-term and large-scale 
expansion of seed cells, but will also facilitate cell tracking 
and detection of the results of tissue engineering. Overall, 
our study provides a potential new method for producing and 
tracking seed cells for skin tissue engineering.
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